Table 3. Changes of organ mass of rat after treatment with galactooligosaccharides and/or bifidobacteria.

Organ		w/(g/100 g)
	Control	HP-GOS	BB	HP-GOS+BB
Liver	9.0±0.1	8.4±0.5	8.7±0.4	8.9±0.2
Kidney	2.3±0.1	2.1±0.1	2.3±0.1	2.3±0.2
Spleen	0.7±0.0	0.6±0.0	0.8±0.0	0.7±0.0

Values are expressed as mean±standard deviation. Control=oral administration of saline, HP-GOS=oral administration of high-purity galactooligosaccharides, BB=oral administration of bifidobacteria, HP-GOS+BB=oral administration of HP-GOS and bifidobacteria